CVS Health (NYSE: CVS) — Company Overview, News & Financial Data
CVS Health operates U.S. pharmacies and clinics, focusing on accessible healthcare services and patient care.
CVS Health
CVS Health is a health services enterprise based in the United States that delivers integrated health care solutions across multiple sectors. The company operates through primary segments including health care benefits, pharmacy benefit management, retail pharmacy operations, and health services. Through its healthcare insurance operations, it provides commercial, Medicare, and Medicaid plans to millions of members. Its pharmacy benefit manager manages prescription drug coverage, formulary design, and specialty services, while its retail network operates thousands of drugstores and walk-in medical clinics across the country to deliver prescription pharmaceuticals, wellness products, and primary clinical services.
Snapshot
Operations
Products and/or services of CVS Health
- Health Insurance: Provides comprehensive commercial, Medicare Advantage, Medicaid, vision, dental, and behavioral health insurance coverage and medical management services to more than 37 million medical members across all fifty states within the United States.
- Pharmacy Benefit Management: Delivers nationwide prescription drug coverage, formulary management, specialty pharmacy services, mail-order drug fulfillment, and clinical program administration to private employers, health plans, union groups, and public sector benefit programs.
- Retail Pharmacy and Consumer Products: Operates over 9,000 community retail drugstores dispensing prescription medications, over-the-counter pharmaceuticals, personal care items, beauty products, and everyday health supplies while offering professional pharmacist consultation services.
- Walk-in Clinics and Primary Care: Delivers retail medical clinic services through more than 1,000 walk-in locations offering treatment for common illnesses, vaccinations, physical exams, routine screenings, and chronic disease management staffed by nurse practitioners.
- In-Home and Value-Based Care: Coordinates home-based health evaluations, technology-enabled clinician visits, and primary care clinic operations focused on value-based care models, preventive health services, and specialized clinical management for senior populations.
- Specialty Pharmacy and Infusion Services: Dispenses complex specialty medications for rare and chronic conditions, while providing specialized clinical support, home infusion therapy, patient education, and targeted therapy management services across the United States.
CVS Health executive team
- J. David JoynerCEO, President & Chairman
- Brian O. NewmanExecutive VP & CFO
- Tilak MandadiEVP of Ventures and Chief Experience & Technology Officer
- Prem S. ShahExecutive VP & Group President
- Steven Hale NelsonExecutive VP & President of Aetna
- James David ClarkSenior VP, Controller & Chief Accounting Officer
- David A. FalkowskiExecutive VP & Chief Compliance Officer
- Samrat S. KhichiExecutive VP of Corporate Affairs & Chief Legal Officer
- Heidi B. CapozziExecutive VP & Chief People Officer
- Gustavo A. GiraldoHead of Markets of Healthcare Benefits
Latest news about CVS Health
Humana jumps 14.4% on Medicare ratings
United StatesHealth insurer stocks decline after 2027 Medicare Advantage plan updates
United StatesCVS Health reports $106.1 billion second-quarter revenue
United StatesCVS Health approves $0.665 quarterly dividend
United StatesCVS Results Beat, Extending Healthcare Win Streak
AustraliaCVS Health Revenue surpasses $100B as integrated care model drives growth
United States
Dividend history
Dividends per share paid by CVS Health , by financial year.
| Financial year | Interim | Final | Special | Total |
|---|---|---|---|---|
| FY2026(to date) | — | — | — | $1.9950 |
| FY2025 | — | — | — | $2.6600 |
| FY2024 | — | — | — | $2.6600 |
| FY2023 | — | — | — | $2.4200 |
| FY2022 | — | — | — | $2.2000 |
Key financials
Reported results for CVS Health , in USD.
- Market cap
- 116.6B
- Revenue (TTM)
- 412.6B
- P/E ratio
- 24.0
- EPS (diluted, TTM)
- 3.8
- Dividend yield
- 2.9%
- Profit margin
- 1.2%
| Fiscal year end | Revenue | Operating income | Net income |
|---|---|---|---|
| 402.1B | 10.4B | 1.8B | |
| 372.8B | 8.5B | 4.6B | |
| 357.8B | 13.7B | 8.3B | |
| 322.5B | 8B | 4.3B |